Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Toxicol Pathol. 2012 Nov 28;41(5):744–760. doi: 10.1177/0192623312464308

Figure 9.

Figure 9

Hepatic fibrosis. Double immunolabelling for MSA (red) and TGF-β1 (brown), hematoxylin counterstain. BPDEC are increased in number, hypertrophied and strongly positive for TGF- β1. HSCs (arrow head) are immunoreactive for MSA. Some HSCs are immunoreactive for MSA and TGF- β1 (arrow). Bar = 20 μm 100X.